Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
AT845 gene replacement therapy for late onset Pompe disease: An update on safety and preliminary efficacy data from FORTIS, a phase I/II open-label clinical study
ÌÇÐÄ´«Ã½
AT845 gene replacement therapy for late onset Pompe disease: An update on safety and preliminary efficacy data from FORTIS, a phase I/II open-label clinical study Manera, J., Mozaffar, T., Day, J. W., Longo, N., Straub, V., Varfaj, F., Chou, H., Maruoka, M., Han, C., Coats, J., Maziere, J. A., Walzer, M., Smith, A. R. ACADEMIC PRESS INC ELSEVIER SCIENCE. 2023: 34-35View details for
View details for